openPR Logo
Press release

The Basic Information About Orlistat

According to statistics from the World Health Organization (WHO), nearly 2 billion people are overweight or obese worldwide. Every year, overweight or obesity causes 2.8 million deaths.

What 's Orlistat ?

Orlistat is a lipase inhibitor used in the treatment of obesity that works by inhibiting fat-metabolizing enzymes. It was originally approved by the FDA in 1999 as the prescription drug Exenical, was approved in 2007 as the over-the-counter medication Alli. This drug is a generally well-tolerated and effective weight-loss aid.

What 's the mechanism of action?

Orlistat is a drug designed to treat obesity. It'sa potent and selective inhibitor of various lipase enzymes responsible for the metabolism of fat. It acts in the gastrointestinal (GI) tract via covalent binding to the serine residues located on the active site of both When orlistat is taken with food containing fat, it partially inhibits the enzymes of triglycerides. This decreases absorption of monoaclglycerides and free fatty acids, contributing to weight maintenance and weight loss.

What 's the side effects of the Orlistat ?

The main side effects of this drug are related to the gastrointestinal tract.

Abdominal pain or discomfort:
Oily discharge from the anus
Gas with oily anal discharge
Oily stools
More-frequent bowel movements
Urgent or hard-to-control bowel movements

Other possible side effects include:
Headache
Back pain
Upper respiratory infection

Huateng Pharma is a global supplier of pharmaceutical intermediates, PEG derivatives, investigateds, APIs and other chemical products. We are dedicated to supplying a wide range of pharmaceutical intermediates to serve customers in the world, such as anti-cancer series, anti-viral series We supply 3-Hexyltetrahydro-4-hydroxy-6-undecyl-2H-pyran-2-one (CAS NO.104801-96-9) with capacities varying from gram to kilograms, anti-diabetic series, antihypertensieve series and so on. It is used in preparation of Orlistat excipient F for quality control of Orlistat and its active pharmaceutical ingredient. This product is an intermediate of Orlistat and ready for mass production.

Hunan Huateng Pharmaceutical Co. Ltd.
Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China
Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China
Email: sales@huatengusa.com
Website: https://us.huatengsci.com
Zip code: 410205
Telephone: +86 731 89916275
Fax: +86 0731-82251112-818

Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We are committed to providing cost-effective pharmaceutical products and services to customers around the world with the belief of "Strive for the Human Health".

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Basic Information About Orlistat here

News-ID: 2562262 • Views: 257

More Releases from Hunan Huateng Pharmaceutical Co. Ltd.

Huateng Pharma Develops Intermediates of Carfilzomib For Multiple Myeloma
Carfilzomib, a proteasome inhibitor, is indicated for the treatment of patients with multiple myeloma. Multiple myeloma (multiple myeloma, MM) is a malignant tumor originating from the B cell lineage, characterized by the clonal proliferation of malignant plasma cells in the bone marrow microenvironment, causing fractures and bone marrow failure, and is the second most common blood system disease in the world Tumors cannot be cured by traditional chemotherapy regimens. Bortezomib is the
Huateng Pharma Develops Intermediates of Semaglutide For TD2
According to the latest IDF Diabetes map, the global prevalence of diabetes reached 10.5% in 2021, with 537 million adults living with diabetes. China has become a disaster zone for diabetes, with the largest number of adults with diabetes in the world. In the past 10 years (2011-2021), the number of people with diabetes in China increased from 90 million to 140 million, an increase of 56%. The total number
The Future of Treatment For Type 2 Diabetes
Although the treatment of type 2 diabetes (T2DM) has made impressive progress in the past few decades, researchers are constantly searching for new treatments. How to better control blood glucose and reduce diabetes-related complications has become a hot topic in the field of T2DM research. Previously, The Lancet Diabetes Endocrinology published an in-depth review detailing novel therapeutic targets for T2DM, mechanisms of drug action, and corresponding hypoglycemic efficacy. It involves innovation
Huateng Pharma Supplies PEG Products As Ingredients In mRNA COVID-19 Vaccines
Since the COVID-19 epidemic, Pfizer and Moderna have used mRNA technology in a vaccine to help humans fight COVID-19. While mRNA technology is new to the public, the research has been around since the early 1990s. What is an mRNA vaccine? An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA (mRNA) to generate an immune response. Such vaccines deliver mRNA molecules into the body's immune cells, where

All 5 Releases


More Releases for Orlistat

Global Orlistat Market 2021 Industry Dynamics, Segmentation and Competition Anal …
MarketsandResearch.biz has introduced a new report titled Global Orlistat Market Growth 2021-2026 into its database that’s shaped by the means of primary and secondary research processes. The report comprises a detailed study of the along with the industry trends, size, share, growth drivers, challenges, competitive analysis, and revenue. The report includes an analysis of the overall global Orlistat market competition as well as the product portfolio of major players functioning in the market.
Orlistat Market Market - Size, Share, Outlook, and Forecast till 2026
Orlistat is a drug that is used to treat obesity by preventing the absorption of fats from human diet. It acts as a lipase inhibitor to carry out this process and therefore, the caloric intake is reduced. This drug is usually used along with a healthcare provider-supervised reduced-calorie diet. Orlistat, a saturated derivative of lipstatin, was chosen for the development of an anti-obesity drug due to its simplicity and stability.
Orlistat Market: Overview with Detailed Analysis, Competitive landscape Forecast …
Orlistat Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Orlistat market research report is a professional and in-depth study on the current state of Orlistat Industry. The Orlistat Market research report covers the present scenario and the growth prospects of the global Orlistat industry
Orlistat Market 2017: Keyplayers Roche, GSK group, Teva, Sandoz(Novartis)
QY Research Groups has published its new and latest market report based on thorough research on the Orlistat Market . This detailed, all-inclusive report renders an integrated approach to growth of the market along with an elaborate and accurate analysis of the complete competitive situation of this market on a global level with the key market trends and newest technologies, being a major part in the market’s growth during the
Orlistat Market to Witness A Pronounce Growth during 2022 Forecast in Top Countr …
The “Global Orlistat Market Research Report” is a professional and in-depth study on the current state of the Orlistat Market. The study offers an insight into current and future market trends, key drivers and restraints, market strategies of key market players along with detailed segmentation and forecast. The study offers industry overview by covering basic aspects such as product definition and classification, market size and share of segments and sub-segments.
Orlistat Pellets Market Analysis - Size, Share, Growth, Forecast, Segment, Appli …
Market Research Globe has published its new and latest market report based on thorough research on the Orlistat Pellets Market. This detailed, all-inclusive report renders an integrated approach to growth of the market along with an elaborate and accurate analysis of the complete competitive situation of this market on a global level with the key market trends and newest technologies, being a major part in the market’s growth during the